Detalhe da pesquisa
1.
Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder.
Curr Oncol Rep
; 25(8): 883-895, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162742
2.
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma.
Cancer
; 126(15): 3493-3503, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469082
3.
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey.
Blood Adv
; 6(9): 2745-2756, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35100356
4.
Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 20(4): 234-243.e10, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32063526
5.
Cost burden of diffuse large B-cell lymphoma.
Expert Rev Pharmacoecon Outcomes Res
; 19(6): 645-661, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31623476
6.
Cost-effectiveness of New Targeted Agents in the Treatment of Chronic Lymphocytic Leukemia.
Cancer J
; 25(6): 418-427, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31764123
7.
Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma.
Expert Rev Hematol
; 12(11): 959-973, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31513757
8.
How should clinicians interpret conflicting cost-effectiveness analyses for the treatment of lymphoma across nations and payer models?
Leuk Lymphoma
; 61(14): 3283-3286, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33143518